Condition
Thoracic Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 16 Thoracic Cancer clinical trials that are recruiting, at sites in 7 countries (most in United States (10), Switzerland (1), Canada (1)). By phase: Phase 1/2 (2), Phase 4 (1), Phase 2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 16Clinical trials
- 7Countries
Newest Thoracic Cancer clinical trials
All recruiting trials (16)
-
LUCINAE Registry: Thoracic Cancers in Pregnancy
This international registry collects data to see how thoracic cancers, including lung cancer, are managed and what outcomes look like for pregnant people and their babies.
-
Heart-friendly medicines to protect chest-area cancer patients from radiation damage
This Phase 2 trial tests whether taking atorvastatin and lisinopril can reduce heart damage in adults with chest-area cancers who receive radiation therapy.
-
Sodium thiosulfate to protect hearing during cisplatin therapy in adults with solid tumors
This study tests Pedmark sodium thiosulfate to see if it reduces hearing loss in adults receiving standard cisplatin chemotherapy.
-
How past alcohol or drug use affects detection and treatment of non-small cell lung cancer
This project will talk with adults who have non-small cell lung cancer and a history of alcohol or drug use to see if those histories help or hinder getting detected and treated.
-
Personalized PULSAR radiotherapy for advanced small cell lung cancer and brain metastases
This trial will try personalized PULSAR radiotherapy schedules to see if they are safe and helpful for adults with extensive-stage small cell lung cancer who need thoracic radiation and for adults with 1–5 brain metastases.
-
Pre-surgery heart and breathing variability to spot risk of complications after major thoracic cancer surgery.
This project will test whether a quick pre-surgery check of heart and breathing variability can help predict which adults having major thoracic cancer operations are more likely to have postoperative complications.
-
Long-term clinical and tissue data collection for people with thoracic cancers
This project will collect medical records, imaging, quality-of-life information, and tissue/blood samples over time from adults with thoracic cancers to try to find factors that predict outcomes.
-
Curative chest re‑irradiation for thoracic cancers
This project will try a standardized high‑dose re‑radiation approach for adults with recurrent or new thoracic cancers who previously received chest radiotherapy to see how well it controls disease and what toxicities occur.
-
TNG462 combined with RAS inhibitors or chemotherapy for MTAP‑loss pancreatic and RAS‑mutant lung cancer
This trial will test whether taking oral TNG462 together with RAS inhibitors or standard chemotherapy is safe and helps people with MTAP‑loss pancreatic cancer or RAS‑mutant non‑small cell lung cancer.
-
Robotic surgery for thoracic cancer using the Medtronic Hugo™ system
This study is testing if using the Medtronic Hugo™ robotic system for thoracic cancer surgery can improve outcomes for patients undergoing procedures like lung resections.
-
Evaluating fatigue and molecular mechanisms in cancer patients undergoing combined chemotherapy and radiation therapy
This study is testing how fatigue affects cancer patients getting both chemotherapy and radiation therapy, and whether certain genes and molecules are linked to how tired they feel during treatment.
-
Collecting health data from lung cancer patients during proton therapy
This study is trying to see if collecting health information from lung cancer patients using devices like smartwatches during their proton therapy can help understand their treatment experience better.
-
Erector spinae block for pain management in thoracic surgery
This study is testing if a special pain relief technique using erector spinae blocks can help patients having lung surgery feel less pain and need fewer pain medications after their operation.
-
Improving access to cancer trials for underrepresented minorities
This study is trying out a new program to help people from underrepresented backgrounds with advanced cancers learn about and access genomic testing for clinical trials.
-
Using stereotactic radiotherapy for treating thoracic tumors
This study tests if a special type of radiation therapy can safely treat chest tumors that are 5cm or smaller while protecting nearby healthy tissue.
-
Evaluating Proton Therapy for Tumors Previously Treated with Radiation
This study is testing a new type of radiation therapy called proton therapy to see if it can help people with tumors that have already been treated with radiation, while causing less harm to healthy tissues.
Related topics
Quick answers
How many Thoracic Cancer clinical trials are recruiting right now?
16, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 7 countries. The most sites are in United States (10 trials), Switzerland (1 trial), Canada (1 trial), Hong Kong (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2, Phase 4: 1, Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.